Last reviewed · How we verify

NCT05318001

Biomechanical and Viscoelastic Properties of Plantar Fascia in Pregnant Women-Pilot Study

Completed Last updated 24 March 2025
What this trial tests

trial testing Evaluation of biomechanics and viscoelastic properties of plantar fascia in Pregnant Women in 172 participants. Completed in 1 August 2024.

Timeline
1 May 2022
Primary endpoint
15 May 2024
1 August 2024

Quick facts

Lead sponsorSultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
StatusCompleted
Study typeOBSERVATIONAL
Enrollment172
Start date1 May 2022
Primary completion15 May 2024
Estimated completion1 August 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

Who can join

Adults 18 to 40, female only, with Pregnant Women. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The feet, which are support surfaces, are adapted to the physiological relaxation and biomechanical changes that occur during pregnancy. In this adaptation, it has not been objectively clarified how the plantar fascia, which plays a very important role in maintaining the height of the plantar arch, undergoes a change. Therefore, the aim of this pilot study is to investigate the normative values of trimester-specific biomechanical and viscoelastic properties of the plantar fascia, which adapts to changes in foot structure during pregnancy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Evaluation of biomechanics and viscoelastic properties of plantar fascia

Trials testing the same drug.

Other recruiting trials for Pregnant Women

Currently open trials in the same condition.

Other Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05318001.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing